The Future of Ketamine and Mood Disorders In 2019, the FDA and European Commission authorized the use of an esketamine nasal spready underneath the manufacturer title Spravato to treat depression. However, as of 2021, ketamine hasn't been approved via the FDA to treat despair or other psychological wellbeing disorders, and for that reason, the medi